Literature DB >> 35670632

Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease.

Chiara Moriconi1, Monika Dzieciatkowska2, Micaela Roy2, Angelo D'Alessandro2, Philippe Roingeard3, June Young Lee4, David R Gibb4, Maria Tredicine5, Marlon A McGill6, Annie Qiu1, Francesca La Carpia1, Richard O Francis1, Eldad A Hod1, Tiffany Thomas1, Martin Picard6, Imo J Akpan7, Chance John Luckey8, James C Zimring9,10, Steven L Spitalnik1, Krystalyn E Hudson1.   

Abstract

Sickle cell disease (SCD) is an inherited blood disorder characterized by sickled red blood cells (RBCs), which are more sensitive to haemolysis and can contribute to disease pathophysiology. Although treatment of SCD can include RBC transfusion, patients with SCD have high rates of alloimmunization. We hypothesized that RBCs from patients with SCD have functionally active mitochondria and can elicit a type 1 interferon response. We evaluated blood samples from more than 100 patients with SCD and found elevated frequencies of mitochondria in reticulocytes and mature RBCs, as compared to healthy blood donors. The presence of mitochondria in mature RBCs was confirmed by flow cytometry, electron microscopy, and proteomic analysis. The mitochondria in mature RBCs were metabolically competent, as determined by enzymatic activities and elevated levels of mitochondria-derived metabolites. Metabolically-active mitochondria in RBCs may increase oxidative stress, which could facilitate and/or exacerbate SCD complications. Coculture of mitochondria-positive RBCs with neutrophils induced production of type 1 interferons, which are known to increase RBC alloimmunization rates. These data demonstrate that mitochondria retained in mature RBCs are functional and can elicit immune responses, suggesting that inappropriate retention of mitochondria in RBCs may play an underappreciated role in SCD complications and be an RBC alloimmunization risk factor.
© 2022 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2022        PMID: 35670632      PMCID: PMC9329257          DOI: 10.1111/bjh.18287

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   8.615


  67 in total

1.  Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice.

Authors:  David R Gibb; Jingchun Liu; Prabitha Natarajan; Manjula Santhanakrishnan; David J Madrid; Stephanie C Eisenbarth; James C Zimring; Akiko Iwasaki; Jeanne E Hendrickson
Journal:  J Immunol       Date:  2017-06-19       Impact factor: 5.422

Review 2.  Noninfectious transfusion-associated adverse events and their mitigation strategies.

Authors:  Ruchika Goel; Aaron A R Tobian; Beth H Shaz
Journal:  Blood       Date:  2019-02-26       Impact factor: 22.113

3.  A three-minute method for high-throughput quantitative metabolomics and quantitative tracing experiments of central carbon and nitrogen pathways.

Authors:  Travis Nemkov; Kirk C Hansen; Angelo D'Alessandro
Journal:  Rapid Commun Mass Spectrom       Date:  2017-04-30       Impact factor: 2.419

4.  High-Throughput Metabolomics: Isocratic and Gradient Mass Spectrometry-Based Methods.

Authors:  Travis Nemkov; Julie A Reisz; Sarah Gehrke; Kirk C Hansen; Angelo D'Alessandro
Journal:  Methods Mol Biol       Date:  2019

5.  Untargeted and Semi-targeted Lipid Analysis of Biological Samples Using Mass Spectrometry-Based Metabolomics.

Authors:  Julie A Reisz; Connie Zheng; Angelo D'Alessandro; Travis Nemkov
Journal:  Methods Mol Biol       Date:  2019

6.  Absolute proteome quantification of highly purified populations of circulating reticulocytes and mature erythrocytes.

Authors:  Emilie-Fleur Gautier; Marjorie Leduc; Sylvie Cochet; Karine Bailly; Catherine Lacombe; Narla Mohandas; François Guillonneau; Wassim El Nemer; Patrick Mayeux
Journal:  Blood Adv       Date:  2018-10-23

7.  Pathophysiology of sickle cell disease is mirrored by the red blood cell metabolome.

Authors:  Dhouha Darghouth; Bérengère Koehl; Geoffrey Madalinski; Jean-François Heilier; Petra Bovee; Ying Xu; Marie-Françoise Olivier; Pablo Bartolucci; Malika Benkerrou; Serge Pissard; Yves Colin; Frederic Galacteros; Giel Bosman; Christophe Junot; Paul-Henri Roméo
Journal:  Blood       Date:  2010-12-06       Impact factor: 22.113

8.  High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.

Authors:  Stella T Chou; Tannoa Jackson; Sunitha Vege; Kim Smith-Whitley; David F Friedman; Connie M Westhoff
Journal:  Blood       Date:  2013-05-30       Impact factor: 22.113

9.  The Role of the Immunological Synapse in Differential Effects of APC Subsets in Alloimmunization to Fresh, Non-stored RBCs.

Authors:  Amanda L Richards; Kathryn Sheldon; Xiaoping Wu; David R Gruber; Krystalyn E Hudson
Journal:  Front Immunol       Date:  2018-10-05       Impact factor: 7.561

10.  Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model.

Authors:  June Young Lee; Emaan Madany; Najwa El Kadi; Sumaarg Pandya; Kessandra Ng; Michifumi Yamashita; Caroline A Jefferies; David R Gibb
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.